Study identifies promising new treatment effective against rare liver disease A new experimental therapy may finally offer ...

Nebokitug is a lab-engineered antibody that targets a molecule called CCL24, a signaling protein known to drive inflammation ...

Researchers report promising results for nebokitug, a monoclonal antibody tested for primary sclerosing cholangitis. In a ...

Researchers have reported encouraging results from a clinical trial of a new monoclonal antibody therapy for primary ...

PSC occurs in 1 out of 10,000 people, who are mostly male adults between 30 and 60 years old, and it commonly develops in patients with inflammatory bowel disease who have ulcerative colitis. The lack ...

A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver ...

Phase II ELMWOOD trial shows elafibranor is well tolerated and improves liver biochemistry and pruritus in primary sclerosing ...

Mr. Means, who co-founded a wellness company, has emerged as one of the most prominent voices in the Make America Healthy Again movement. By Dani Blum Calley Means, a health care entrepreneur and key ...

After their shameful approval of Robert F. Kennedy Jr. as Health and Human Services secretary, the Senate Committee on Health, Education, Labor and Pensions has an opportunity to redeem itself when it ...

Caroline Linton is an associate managing editor on the political team for CBSNews.com. She has previously written for The Daily Beast, Newsweek and amNewYork. Nikole Killion is a CBS News ...